Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis
Chastre A, Hafler DA, O'Connor KC. Evaluation of KIR4.1 as an Immune Target in Multiple Sclerosis. New England Journal Of Medicine 2016, 374: 1495-1496. PMID: 27074083, PMCID: PMC4918464, DOI: 10.1056/nejmc1513302.Peer-Reviewed Original ResearchConceptsMultiple sclerosisEnzyme-linked immunosorbentSpecific autoantibodiesImmune targetsHealthy controlsSclerosisPatientsKir4.1AutoantibodiesImmunosorbentSerumAntibodies